Zobrazeno 1 - 10
of 16
pro vyhledávání: ''
Publikováno v:
SpringerPlus
Patients’ preferences increasingly play roles in cancer treatments. The objective of this study is to examine breast cancer patients’ preferences and willingness-to-pay (WTP) for postmenopausal hormone receptor-positive, HER2-negative advanced br
Publikováno v:
SpringerPlus
We previously described a menstrual heat cycle of the breast in four groups of women (healthy, family history of breast cancer, benign breast disease, ‘cancer-associated’) who wore a thermometric brassiere (Chronobra). We now ask if ‘breast min
Publikováno v:
SpringerPlus
Tumour stroma ratio (TSR) is emerging as an important prognostic indicator in cancer. We have previously shown TSR to be prognostic in oestrogen receptor positive breast cancer. Its role in inflammatory breast cancer, a rare but aggressive form of br
Autor:
Kimberly A. Gudzune, Rochelle Brown, Susan Hutfless, Oluwakemi A Fawole, Nisa M. Maruthur, Jodi B Segal, Zoobia W Chaudhry, Renee F Wilson
Publikováno v:
SpringerPlus
Background Obesity affects cancer risk and treatment outcomes. Preventing weight gain may prevent some cancers, improve cancer outcomes, reduce cancer recurrence and increase cancer-related survival. We performed a systematic review to identify strat
Autor:
Hassan Jouhadi, Chaymaa Marouf, Amal Tazzite, Sellama Nadifi, Brehima Diakite, Omar Hajji, Abdellatif Benider
Publikováno v:
SpringerPlus
Purpose The cell-cycle checkpoint kinase 2 (CHEK2) is an important signal transducer of cellular responses to DNA damage, whose defects has been associated with increased risk for breast cancer. The CHEK2 1100delC mutation has been reported to confer
Publikováno v:
SpringerPlus
Growing evidence from recent studies has revealed that microRNA-203 (miR-203) might be an attractive prognostic biomarker for cancer. But controversy still remains. The aim of this meta-analysis was to summarize available evidences and clarify the pr
Autor:
J. Esteban Castelao, Francisco Gude, Alejandro Novo Domínguez, Maite Peña Fernandez, Maria Elena Martinez, Manuela Gago-Dominguez, Víctor Muñoz Garzón, Carmen M. Redondo, Manuel Enguix Castelo, Sara Miranda Ponte, Angel Carracedo, Miguel E. Aguado-Barrera
Publikováno v:
SpringerPlus
Although alcohol intake is an established risk factor for overall breast cancer, few studies have looked at the relationship between alcohol use and breast cancer risk by the four major subtypes of breast cancer and very few data exist in the alcohol
Autor:
Rachel Ballard-Barbash, Leslie Bernstein, Richard N. Baumgartner, Catherine Duggan, Kathy B. Baumgartner, Anne McTiernan
Publikováno v:
SpringerPlus
Purpose Here we assessed associations between null mutations in glutathione-S-transferase (GST)T1 and GSTM1 genes, and the rs1695 polymorphism in GSTP1 (Ile105Val), and risk of breast cancer-specific (n=45) and all-cause (n=99) mortality in a multiet
Autor:
Ikuro Sato, Masaaki Kawai, Noriaki Ohuchi, Yoshikazu Nishino, Yuko Minami, Yoichiro Kakugawa, Kayoko Fukamachi
Publikováno v:
SpringerPlus
An association of cigarette smoking with breast cancer risk has been hypothesized. However, results from previous studies have been inconsistent. This case-control study investigated the association of cigarette smoking with breast cancer risk in ter
Autor:
Stefan Feiten, Kristina Kleboth, Jochen Heymanns, Christoph van Roye, Jörg Thomalla, Hubert Köppler, Rudolf Weide, Vera Friesenhahn
Publikováno v:
SpringerPlus
18,000 women die due to metastatic breast cancer in Germany per year. Median survival is 20–28 months after diagnosis. The question we wanted to answer was whether survival has improved in routine care? For this purpose we conducted a retrospective